Multiple Sclerosis

Nicoline Schiess; Peter A. Calabresi

doi:10.1055/s-0036-1585456

Multiple Sclerosis

Nicoline Schiess, Peter A. Calabresi

School of Medicine

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

It is estimated that there are 300,000 people with multiple sclerosis (MS) in the United States and 2.3 million worldwide. Each MS attack can affect function in cognitive, emotional, motoric, sensory, or visual domains. Patients are often struck in the prime of their lives as they attempt to move forward with career, and family. Since the previous 2010 Seminars in Neurology Pearls and Pitfalls issue, the world of MS has drastically changed and advanced. Here the authors address the ever-changing MS world in both treatment options and diagnostics, covering easily missed differential diagnoses, newly available immunomodulatory therapy, and the challenges of safely treating patients.

Original language	English (US)
Pages (from-to)	350-356
Number of pages	7
Journal	Seminars in neurology
Volume	36
Issue number	4
DOIs	https://doi.org/10.1055/s-0036-1585456
State	Published - Aug 1 2016

Keywords

immunomodulatory treatment
multiple sclerosis

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1055/s-0036-1585456

Cite this

@article{5ab5c22456cf40e7a09d29d2356148be,

title = "Multiple Sclerosis",

abstract = "It is estimated that there are 300,000 people with multiple sclerosis (MS) in the United States and 2.3 million worldwide. Each MS attack can affect function in cognitive, emotional, motoric, sensory, or visual domains. Patients are often struck in the prime of their lives as they attempt to move forward with career, and family. Since the previous 2010 Seminars in Neurology Pearls and Pitfalls issue, the world of MS has drastically changed and advanced. Here the authors address the ever-changing MS world in both treatment options and diagnostics, covering easily missed differential diagnoses, newly available immunomodulatory therapy, and the challenges of safely treating patients.",

keywords = "immunomodulatory treatment, multiple sclerosis",

author = "Nicoline Schiess and Calabresi, {Peter A.}",

note = "Publisher Copyright: {\textcopyright} 2016 by Thieme Medical Publishers, Inc.",

year = "2016",

month = aug,

day = "1",

doi = "10.1055/s-0036-1585456",

language = "English (US)",

volume = "36",

pages = "350--356",

journal = "Seminars in neurology",

issn = "0271-8235",

publisher = "Thieme Medical Publishers, Inc.",

number = "4",

}

TY - JOUR

T1 - Multiple Sclerosis

AU - Schiess, Nicoline

AU - Calabresi, Peter A.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - It is estimated that there are 300,000 people with multiple sclerosis (MS) in the United States and 2.3 million worldwide. Each MS attack can affect function in cognitive, emotional, motoric, sensory, or visual domains. Patients are often struck in the prime of their lives as they attempt to move forward with career, and family. Since the previous 2010 Seminars in Neurology Pearls and Pitfalls issue, the world of MS has drastically changed and advanced. Here the authors address the ever-changing MS world in both treatment options and diagnostics, covering easily missed differential diagnoses, newly available immunomodulatory therapy, and the challenges of safely treating patients.

AB - It is estimated that there are 300,000 people with multiple sclerosis (MS) in the United States and 2.3 million worldwide. Each MS attack can affect function in cognitive, emotional, motoric, sensory, or visual domains. Patients are often struck in the prime of their lives as they attempt to move forward with career, and family. Since the previous 2010 Seminars in Neurology Pearls and Pitfalls issue, the world of MS has drastically changed and advanced. Here the authors address the ever-changing MS world in both treatment options and diagnostics, covering easily missed differential diagnoses, newly available immunomodulatory therapy, and the challenges of safely treating patients.

KW - immunomodulatory treatment

KW - multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84988474056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988474056&partnerID=8YFLogxK

U2 - 10.1055/s-0036-1585456

DO - 10.1055/s-0036-1585456

M3 - Article

C2 - 27643903

AN - SCOPUS:84988474056

SN - 0271-8235

VL - 36

SP - 350

EP - 356

JO - Seminars in neurology

JF - Seminars in neurology

IS - 4

ER -

Multiple Sclerosis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this